I. Muller et al., ANTHRACYCLINE-DERIVED CHEMOTHERAPEUTICS IN APOPTOSIS AND FREE-RADICALCYTOTOXICITY (REVIEW), INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 491-494
Anthracycline-derivatives are frequently used chemotherapeutics in tre
atment of numerous human malignancies. Anthracyclines are known for th
eir complex cytotoxic mechanism involving i) inhibition of enzymes suc
h as topoisomerase II, RNA polymerase, cytochrome c oxidase and others
; ii) intercalation into DNA; iii) chelation of iron and generation of
reactive oxygen species (ROS); iv) induction of apoptosis. Here, mech
anistic aspects for successful cytostasis and for side effects, e.g. c
ardiomyopathy, are discussed. We emphasize recent developments in anth
racycline-mediated apoptosis and focus on a well known representative,
doxorubicin (adriamycin, adriblastin). We reflect on the role of oxid
ative stress and interactions with intracellular signaling pathways.